Frontlight ResearchEarly access
Trial site
Cancer Care Northwest
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Metastatic breast cancer2 trials
- Brain metastases1 trial
- Colorectal cancer1 trial
- Head and neck cancer1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 1/23 trials
- Phase 23 trials
- Phase 31 trial
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Completed2 trials
- Terminated2 trials
- Lead sponsor
- BeiGene3 trials
- Tempus AI2 trials
- BriaCell Therapeutics Corporation1 trial
- Criterium, Inc.1 trial
- Galera Therapeutics, Inc.1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Terminated
Completed
Terminated
Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer
Site data: ClinicalTrials.govUpdated 15 Nov 2026